Global Bioactive Peptides Market
Bioactive peptides are amino acids combined together through a covalent bond. Bioactive peptides are extracted from various natural sources, thereby providing a variety of health benefits such as better cardiovascular, digestive, endocrine functioning, as well as the immune and nervous system. They are also used in protecting important contents of food and beverages, resulting in decreased oxidation and degradation of the products. Although these peptides are extracted from natural sources, some of them have been designed using chemical synthesis processes.
A sample of this report is available upon request @ https://www.coherentmarketinsights.com/insight/request-sample/3018
Furthermore, bioactive peptides, as well as bioactive proteins are part of a balanced diet. The prominent factor driving the market demand is increasing incidence of chronic diseases, and growing geriatric population. Moreover, growing interest in bioactive peptides is driving the scientific community and the food industry to develop new food additives and functional products based on bioactive peptides.
The global bioactive peptide market was pegged at US$ 3,265.2 million in 2017, and is expected to exhibit a staggering 9.4% CAGR over the forecast period (2018-2026).
Key Market Players
The major players operating in the global bioactive peptides market include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., and Valio Oy.
Rising incidence of chronic diseases propelling the global bioactive peptides market growth
Increasing incidence of diseases like diabetes, cancer, and respiratory disorders is expected to bolster the growth of the global bioactive peptides market. According to the International Federation of Diabetes, 2017 report, around 425 million adults were suffering from diabetes globally, and the number is expected to reach 629 million by 2045.
According to a press release on September 2018 by the International Agency for Research on Cancer, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Moreover, 1 in 5 men, and 1 in 6 women worldwide develop cancer during their lifetime, and 1 in 8 men, and 1 in 11 women die from the disease.
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/3018
As per the World Health Organization statistics, an estimated 3.17 million incidences of chronic obstructive pulmonary disease (COPD) were recorded in 2015, of which COPD accounted for 5% of the total death count. More than 90% of COPD incidences occur in low and middle income countries.
Innovations and products launches by market players is expected to drive growth of the bioactive peptides market during the forecast period. In November 2018, Nuritas Ltd., announced the commercial launch of Peptide which contains anti-inflammatory bioactive peptides. It was the first bioactive ingredient discovered and delivered through artificial intelligence.
Growing demand for nutritional supplements worldwide
Increasing awareness among the global populace about the disease conditions, owing to the increasing number of initiatives and campaigns by government organizations, along with escalating healthcare spending by government organizations, is projected to fuel the growth of the global bioactive peptides market in the near future. According to Council for Responsible Nutrition (CRN) Washington, October 2018, Consumer Survey on Dietary Supplements, conducted by Ipsos Public Affairs found that 75% of U.S. adults take dietary supplements in 2018, as compared to 65% in 2009.
Furthermore, strategic collaborations between market players for development of innovative products is expected to facilitate demand for bioactive peptides. For instance, in December 2018, Nestle and Nuritas Ltd. collaborated to discover food derived bioactive peptides.
Browse Press Release: https://bit.ly/2WGltSa
Detailed Segmentation:
- Global Bioactive Peptide Market, By Source:
- Plant
- Milk
- Eggs
- Meat
- Fish
- Global Bioactive Peptide Market, By Therapeutic Area:
- Antihypertensive
- Antioxidant
- Immunostimulatory
- Antimicrobial
- Diabetes
- Others
- Global Bioactive Peptide Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: : sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837